DrugPatentWatch Database Preview
DERMATOP Drug Profile
or, see our see our flat-rate plans
When do Dermatop patents expire, and what generic alternatives are available?
The generic ingredient in DERMATOP is prednicarbate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prednicarbate profile page.
Summary for DERMATOP
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Bulk Api Vendors: | 30 |
| Patent Applications: | 2,294 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DERMATOP at DailyMed |
Synonyms for DERMATOP
| (11|A)-17-[(Ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
| [2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate |
| [2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate |
| 11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl carbonate) 21-propionate |
| 73771-04-7 |
| 771P047 |
| AB00514017 |
| AB2000755 |
| AC-3521 |
| AC1O8Q04 |
| AKOS025402043 |
| AN-6763 |
| API0009173 |
| BC226387 |
| BPBio1_001066 |
| BRD-K46137903-001-03-3 |
| BSPBio_000968 |
| CAS-73771-04-7 |
| CCG-221044 |
| CHEBI:135791 |
| CHEMBL1200386 |
| D05601 |
| D09IEE |
| DB01130 |
| Dermatop (TN) |
| Dermatop E emollient |
| DSSTox_CID_25502 |
| DSSTox_GSID_45502 |
| DSSTox_RID_80919 |
| DTXSID9045502 |
| EINECS 277-590-3 |
| GTPL7605 |
| HMS1571A10 |
| HMS2098A10 |
| HMS2230O11 |
| Hoe 777 |
| Hoe-777 |
| MLS002154121 |
| NCGC00016926-01 |
| NCGC00179357-01 |
| Peitel |
| Prednicarbat |
| PREDNICARBATE |
| Prednicarbate (USP/INN) |
| Prednicarbate [USAN:USP:INN:BAN] |
| Prednicarbato |
| Prednicarbato [INN-Spanish] |
| Prednicarbatum |
| Prednicarbatum [INN-Latin] |
| Prednisolone 17-(Ethyl Carbonate) 21-Propionate |
| Prednitop |
| Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11beta)- |
| Pregna-1,4-diene-3,20-dione,17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11b)- |
| Prestwick0_001044 |
| Prestwick1_001044 |
| Prestwick2_001044 |
| Prestwick3_001044 |
| Q-101379 |
| Regenit |
| S 77 0777 |
| S 77-0777 |
| S 770777 |
| S-77 0777 |
| S-770777 |
| SC-81331 |
| SCHEMBL3941 |
| SMR001233428 |
| SPBio_002904 |
| SR-01000841201 |
| SR-01000841201-2 |
| Tox21_110687 |
| UNII-V901LV1K7D |
| V901LV1K7D |
| ZINC3938652 |
US Patents and Regulatory Information for DERMATOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms North | DERMATOP | prednicarbate | OINTMENT;TOPICAL | 019568-001 | Sep 23, 1991 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Valeant Bermuda | DERMATOP E EMOLLIENT | prednicarbate | CREAM;TOPICAL | 020279-001 | Oct 29, 1993 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
Expired US Patents for DERMATOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms North | DERMATOP | prednicarbate | OINTMENT;TOPICAL | 019568-001 | Sep 23, 1991 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
or, see our see our flat-rate plans
